|
Name |
S 39163/F-1
|
| Molecular Formula | C38H60O9 | |
| IUPAC Name* |
6-(3,9-dihydroxy-2,6,8,10,14,16,18-heptamethylicosa-4,6,12,14-tetraen-2-yl)-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one
|
|
| SMILES |
CCC(C)CC(C)C=C(C)C=CCC(C)C(O)C(C)C=C(C)C=CC(O)C(C)(C)c1cc(O)c(C2OC(CO)CC(O)C2O)c(=O)o1
|
|
| InChI |
InChI=1S/C38H60O9/c1-10-22(2)16-25(5)17-23(3)12-11-13-26(6)34(43)27(7)18-24(4)14-15-31(42)38(8,9)32-20-29(40)33(37(45)47-32)36-35(44)30(41)19-28(21-39)46-36/h11-12,14-15,17-18,20,22,25-28,30-31,34-36,39-44H,10,13,16,19,21H2,1-9H3/b12-11+,15-14+,23-17+,24-18+/t22?,25?,26?,27?,28-,30-,31?,34?,35+,36-/m1/s1
|
|
| InChIKey |
WAZIGTZFSDENTL-HWHANDHNSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 660.89 | ALogp: | 5.6 |
| HBD: | 6 | HBA: | 9 |
| Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 160.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 47 | QED Weighted: | 0.121 |
| Caco-2 Permeability: | -5.226 | MDCK Permeability: | 0.00000865 |
| Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.977 |
| Human Intestinal Absorption (HIA): | 0.894 | 20% Bioavailability (F20%): | 0.017 |
| 30% Bioavailability (F30%): | 0.948 |
| Blood-Brain-Barrier Penetration (BBB): | 0.181 | Plasma Protein Binding (PPB): | 96.24% |
| Volume Distribution (VD): | 1.808 | Fu: | 3.15% |
| CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.13 |
| CYP2C19-inhibitor: | 0.007 | CYP2C19-substrate: | 0.906 |
| CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.856 |
| CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.492 |
| CYP3A4-inhibitor: | 0.341 | CYP3A4-substrate: | 0.759 |
| Clearance (CL): | 8.352 | Half-life (T1/2): | 0.179 |
| hERG Blockers: | 0.575 | Human Hepatotoxicity (H-HT): | 0.876 |
| Drug-inuced Liver Injury (DILI): | 0.013 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.286 | Maximum Recommended Daily Dose: | 0.975 |
| Skin Sensitization: | 0.938 | Carcinogencity: | 0.048 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
| Respiratory Toxicity: | 0.943 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002883 | ![]() |
0.384 | D0N3NO | ![]() |
0.199 | ||
| ENC002839 | ![]() |
0.384 | D09CZA | ![]() |
0.195 | ||
| ENC004780 | ![]() |
0.384 | D03SVX | ![]() |
0.187 | ||
| ENC004855 | ![]() |
0.302 | D02RQU | ![]() |
0.184 | ||
| ENC002816 | ![]() |
0.285 | D04RGA | ![]() |
0.182 | ||
| ENC002660 | ![]() |
0.284 | D0B1IP | ![]() |
0.182 | ||
| ENC004938 | ![]() |
0.284 | D0T5XN | ![]() |
0.178 | ||
| ENC005725 | ![]() |
0.282 | D0L7AS | ![]() |
0.178 | ||
| ENC004261 | ![]() |
0.271 | D0G5CF | ![]() |
0.176 | ||
| ENC003820 | ![]() |
0.268 | D03KIA | ![]() |
0.176 | ||